BRC Inc. Receives NYSE Non-Compliance Notice for Sub-$1.00 Share Price
summarizeSummary
BRC Inc. received a notice from the NYSE for failing to maintain a minimum average closing price of $1.00 per share, initiating a six-month period to regain compliance and avoid potential delisting.
check_boxKey Events
-
NYSE Non-Compliance Notification
BRC Inc. received a notice from the NYSE on February 11, 2026, for non-compliance with Section 802.01C, as its Class A Common Stock traded below an average closing price of $1.00 per share for 30 consecutive trading days.
-
Six-Month Compliance Period
The company has a six-month period from the receipt of the notice to regain compliance. It can achieve this if its stock closes at or above $1.00 and maintains an average closing price of at least $1.00 over a 30-day period ending on the last trading day of any calendar month within the cure period.
-
Company Response and Intent
BRC Inc. intends to notify the NYSE within ten business days of its plan to cure the deficiency and is evaluating available alternatives to regain compliance, prioritizing actions in the best interest of the company and its shareholders.
auto_awesomeAnalysis
BRC Inc. has received a formal notification from the NYSE indicating non-compliance with the minimum average closing price requirement of $1.00 per share. This is a critical event as failure to regain compliance within the six-month cure period could lead to delisting, significantly impacting the company's visibility, liquidity, and ability to attract institutional investment. While there is no immediate effect on trading, the company must actively pursue strategies, such as a reverse stock split, to boost its share price above the threshold. Investors should monitor the company's progress in addressing this deficiency closely, as continued weakness could lead to further negative sentiment and potential delisting.
At the time of this filing, BRCC was trading at $0.73 on NYSE in the Manufacturing sector, with a market capitalization of approximately $181.2M. The 52-week trading range was $0.68 to $2.78. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.